| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/22/2006 | EP1627642A2 Zinc free insulin crystals for use in pulmonary compositions |
| 02/22/2006 | EP1627636A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 02/22/2006 | EP1627634A1 Composition for lowering lipid in body |
| 02/22/2006 | EP1627632A1 Therapeutic agent |
| 02/22/2006 | EP1626738A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 02/22/2006 | EP1626716A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/22/2006 | EP1626715A1 Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385856B1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/22/2006 | EP1251857B1 Pharmaceutical parenteral composition containing a bisphosphonate |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1093370B1 Pharmaceutical composition for the treatment of diabetes |
| 02/22/2006 | EP1051193B1 Anhydrous topical skin preparation comprising ketoconazole |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738795A Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738633A Anti-obesity ingretients from medicinal plants and their composittion |
| 02/22/2006 | CN1738630A Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same |
| 02/22/2006 | CN1738617A Pharmaceutical compositions for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 02/22/2006 | CN1737103A Propolis wine |
| 02/22/2006 | CN1736977A crystallized (+)-(1S,2S,3S,4R,5R)-1-amido-5-hydroxymethyl-N-2(1,3-dihydroxypropyl)-2,3,4-cyclohexanetriol and its preparation method |
| 02/22/2006 | CN1736478A Composition for lowering blood fat |
| 02/22/2006 | CN1736477A Application of combination of cytokine and hypoglycemic in treatment of diabetes |
| 02/22/2006 | CN1736462A Chinese proprietary medicine making fleece-flower root as main raw material |
| 02/22/2006 | CN1736461A Composite vegetable drug for treating type II diabetes and increasing insulin sensitivity, extracts and extraction method |
| 02/22/2006 | CN1736459A Medicine for treating diabetes and its preparing process |
| 02/22/2006 | CN1736458A Diabetes treating Chinese medicine |
| 02/22/2006 | CN1736456A Extracts of composite Chinese medicinal plants for treating diabetic gastrointestinal disease and extraction method |
| 02/22/2006 | CN1736398A Effervescence pharmaceutical composition |
| 02/22/2006 | CN1736385A Composition containing ganglioside, jphosphatidyl inositol and/or inositol and application thereof |
| 02/22/2006 | CN1736384A Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation |
| 02/22/2006 | CN1736377A Novel composition and use |
| 02/22/2006 | CN1736376A Modulation of peroxisome proliferator-activated receptors |
| 02/22/2006 | CN1736372A Compound amino acid for injection and its preparation process |
| 02/22/2006 | CN1736262A Composition containing flavonoid, jphosphatidyl inositol and/or inosite |
| 02/22/2006 | CN1736230A Fat-lowering weight-decreasing tea and preparation process thereof |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242994C Novel heterocyclic compound and medicinal use thereof |
| 02/22/2006 | CN1242813C Combination therapy for osteoporosis |
| 02/22/2006 | CN1242776C Worm nutritious health oral liquid and its preparing method |
| 02/22/2006 | CN1242769C Preparation capable of promoting growth and intelligence development for teenagers and children as well as its preparing method |
| 02/22/2006 | CN1242747C Compound baking soda injection and its preparation |
| 02/22/2006 | CN1242741C Preparation and diabetic use of gibberellins |
| 02/21/2006 | US7002030 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7001920 Psychological disorders; antidepressant |
| 02/21/2006 | US7001919 Crystallization from solvent system |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
| 02/21/2006 | US7001908 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/21/2006 | US7001896 Side effect reduction; antidiabetic agents; using 4-diethylphosphinoylmethyl-N-(-4-bromo-2-cyanopheny)benzamide |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001621 Blends of ursolic acid/oleanolic acid |
| 02/21/2006 | CA2110443C Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 02/16/2006 | WO2006017627A2 Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance |
| 02/16/2006 | WO2006016695A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 02/16/2006 | WO2006016637A1 Novel cyclic aminobenzoic acid derivative |
| 02/16/2006 | WO2006016602A1 Nateglinide-containing preparation reduced in bitterness |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006015522A1 A capsule for regulation of blood pressure and hyperlipemia and prevention and treatment of cardiovascular and cerebrovascular diseases |
| 02/16/2006 | WO2005115378B1 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 02/16/2006 | WO2005115377B1 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 02/16/2006 | WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035977 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f |
| 02/16/2006 | US20060035964 Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 02/16/2006 | US20060035941 Calcium salts of indole derived statins |
| 02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/16/2006 | US20060035928 for diabetes mellitus and other metabolic disorders; compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 02/16/2006 | US20060035873 Methods for inducing apolipoprotein e secretion |
| 02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 02/16/2006 | US20060035844 Preventive or remedy for diseases caused by hyperglycemia |
| 02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/16/2006 | US20060035818 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035209 Screening method |
| 02/16/2006 | US20060034949 Remedy |
| 02/16/2006 | US20060034896 triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 02/16/2006 | US20060034895 Supplement food for low blood glucose recovery |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034818 Placental alkaline phosphatase to control diabetes |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | DE102004035322A1 Selektive Hemmstoffe humaner Corticoidsynthasen Selective inhibitors of human Corticoidsynthasen |
| 02/16/2006 | DE102004035113A1 Composition for treating symptoms of cystic fibrosis comprises alpha-lipoic acid or a derivative thereof as the sole active ingredient |
| 02/16/2006 | DE102004034640A1 Verfahren zur systemischen Biokorrektur eines Organismus Method for systemic Biokorrektur an organism |
| 02/16/2006 | DE102004034573A1 Composition for treating pulmonary and coronary vascular diseases and metabolic diseases comprises L-arginine/ornithine, L-lysine, L-carnitine and L-cysteine in an isotonic sodium chloride solution |
| 02/16/2006 | DE102004033405A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2576505A1 Combination of bupropion and a second compound for affecting weight loss |
| 02/16/2006 | CA2576407A1 Substituted phenylacetamides and their use as glucokinase activators |